GaBio - Georgia Bio
08/21/2026 | Press release | Distributed by Public on 08/21/2026 09:15
Georgia’s Life Sciences Momentum is Getting Noticed Nationally.
Genetic Engineering & Biotechnology News (GEN) has named Georgia #4 among its "Next 5 States" for emerging U.S. biopharma clusters.
The article highlights UCB's planned $2 billion investment at in Gwinnett County, Micron Biomedical's new Alpharetta facility, Manus Bio's expansion in Augusta, Science Square, Emory University, the CDC - and Georgia Life Sciences' 10-year Life Sciences Roadmap.
This recognition is exciting. But even more importantly, it validates the work happening across our entire ecosystem - and perfect momentum as we head into the 2026 Georgia Life Sciences Summit next week.
Read more by visiting: Next 10 U.S. Biopharma Clusters
GaBio - Georgia Bio published this content on August 21, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on August 21, 2026 at 15:15 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]